Clinical Trial Update: Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields [Phase 2]

View source ↗

Summary

A Phase 2 study is evaluating whether topical clindamycin and triamcinolone can prevent skin-related side effects in patients with glioblastoma treated with tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Clindamycin
• Triamcinolone (triamcinolone)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING